The Swedish biotech hopes its precision therapy will help patients with advanced solid tumors who currently have few ...

The French biotech company Nanobiotix announced today that it has dosed the first patient in the CONVERGE study, a Phase 2 ...

Josh Gissing is Cluster Head (UK, Ireland & Nordics) for Biocon Biologics: a biosimilars company whose business model seeks ...

Diane Lacroix, Vice President of Clinical Data Management at eClinical Solutions, talks personalised medicine, data decisions ...

As Director of R&D at Sunflower Therapeutics, Laura Crowell works with a team developing biologic medicines and vaccines. She ...

The oversubscribed Series C financing round will support the clinical development of in vivo CAR-T cells for oncology and ...

The US gene therapy company Regenxbio and the Japanese firm Nippon Shinyaku have joined forces to boost the development and ...

The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...

MaaT Pharma is focused on developing microbiome-related therapies and its lead candidate is MaaT013, a treatment for acute ...

The Swiss drug development company Windward Bio recently announced that it had officially launched with a $200 million Series ...

The UK biopharma company Alchemab Therapeutics announced today that it has joined forces with Eli Lilly to discover, develop, ...